Srinivas Akkaraju and Samsara Biocapital, L.P. Receives Stock Award at Mineralys Therapeutics Inc (MLYS) — SEC Form 4, Feb 24, 2025
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Reporting Owners
Director
10% Owner
TXN 2025-02-13
·
FILED 2025-02-24
Filing Lag
6 business days
late vs 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owners
| Name | Relationship |
|---|---|
| Srinivas Akkaraju CIK 0001253170 |
Director
10% Owner
|
| Samsara Biocapital, L.P. CIK 0001699737 |
10% Owner
|
Srinivas Akkaraju at Mineralys Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Mineralys Therapeutics Inc
| 2026-02-20 | Award | — | View |
| 2025-09-09 | Buy | +$14,999,992 | View |
| 2025-03-18 | Buy | +$8,100,000 | View |
| 2024-05-23 | Award | — | View |
| 2024-02-14 | Award | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $10.20 | 2025-02-13 | A - Award/Grant | 32,900 A | $0.00 | 2035-02-13 | 32,900 Common Stock | Direct |
Footnotes (1)
- F1
- The stock option vests in 12 substantially equal monthly installments following the date of grant. Show more
Related filings at Mineralys Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
225
institutional managers reporting a position
Largest by reported value
- Catalys Pacific, Llc $213M
- Ra Capital Management, L.P. $208M
- Black Rock, Inc. $159M
5%+ Holders · 13D/G
5 filers
-
Fmr Llc 5.1%
-
Catalys Pacific Fund, LP 10.1%
-
Black Rock, Inc. 5.2%
Other insiders at Mineralys Therapeutics Inc
-
Jon Congleton -$1.91M
-
Brian Taylor Slingsby -$3.01M
-
Eric Warren -$209K
GET /v1/forms/4/0001933414-25-000018
API docs
View Original SEC Filing